Dr. Evans’ work seeks to understand the effects of nicotine on attention and related cognitive processes. The capacity to pay attention is important and necessary for the efficient completion of daily tasks, and some smokers may find smoking more reinforcing because of nicotine’s capacity to enhance attentional control. Dr. Evans is currently working on funded projects that examine genetic moderation of the effects of nicotine on attention and related cognitive processes. Preliminary findings from these studies suggest that brain chemical-related genetic variants may moderate the effects of nicotine on neural indices of attentional control. Individuals with genetic variants associated with suboptimal brain activity may experience greater cognitive benefits from nicotine, suggesting nicotine self medication of cognitive processing. This research program may contribute to the development of tailored behavioral and/or pharmacotherapy treatment programs that target individual smoker characteristics (e.g., smokers with attentional deficits).